Evidence map›Paper›PMID 41247515›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer.

Christian Hoffmann, Hubertus Hautzel, Marcel Wiesweg, David Kersting, Nika Guberina, Christoph Pöttgen, Martin Metzenmacher, Martin Schuler, Thomas Gauler, Benedikt Höing and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Christian HoffmannDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany. christian.hoffmann2@uk-essen.de.ORCID 0000-0002-5776-439X
Hubertus HautzelNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Marcel WieswegNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
David KerstingGerman Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Essen, Germany.
Nika GuberinaDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Christoph PöttgenDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Martin MetzenmacherNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Martin SchulerNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Thomas GaulerDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Benedikt HöingNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Cornelius KürtenNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Fabian DoerrNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Servet BölükbasNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Natalie BaldesNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Marcel OpitzNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Aleksandar MilosevicNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Felix NensaNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Lale UmutluNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Faustina FunkeGerman Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Essen, Germany.
Wolfgang P FendlerNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Ken HerrmannNCT West, National Center for Tumor Diseases (NCT), Essen, Germany.
Martin StuschkeDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Maja GuberinaDepartment of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg - Essen, Hufelandstrasse 55, Essen, 45147, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEvaluation of interim-[

methodsWe included 35 patients with limited disease SCLC from a prospective institutional registry in this retrospective study. Patients received induction chemotherapy (3-4 cycles) followed by concurrent radiochemotherapy. Baseline [

resultsAll patients underwent twice-daily radiotherapy to a base dose of 45 Gy. SUV

conclusionOur decay model enables the characterization of [

Indexed as

ChemoradiotherapyFluorodeoxyglucose F18Induction ChemotherapyLung NeoplasmsPositron Emission Tomography Computed TomographySmall Cell Lung CarcinomaAdultAgedAged, 80 and overFemaleHumansKineticsMaleMiddle AgedNeoplasm StagingRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG-PET/CTPrognosticRadiotherapySmall cell lung cancerTreatment response

Identifiers

PMID41247515
PMCPMC13013332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.